GBI Research Market Research Reports

Title published price

Global Women's Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth

By GBI Research

Global Women's Health Drugs Market to 2024 - Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth Summary The women's health therapy area covers medical disorders tha ...

01-Jan-2019 $4995

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry

By GBI Research

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry Summary The rheumatic disorder therapy area is multi-disciplinary in ...

01-Jan-2019 $4995

Gastrointestinal Diseases Drug Development Pipeline Review, 2018

By GBI Research

Summary This report provides an overview of the pipeline landscape for gastrointestinal diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic developm ...

20-Dec-2018 $3995

Renal Diseases Drug Development Pipeline Review, 2018

By GBI Research

Summary This report provides an overview of the pipeline landscape for renal diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for chr ...

19-Dec-2018 $3995

Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

By GBI Research

Summary Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with ...

15-Dec-2018 $4995

Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market

By GBI Research

Summary Non-alcoholic steatohepatitis (NASH) is the severe form of non-alcoholic fatty liver disease (NAFLD), characterized by a buildup of fat in the liver. Globally, the NAFLD prevalence rate is estimated to be around 25 ...

03-Dec-2018 $4995

Chronic Respiratory Disease Drug Development Pipeline Review, 2018

By GBI Research

Summary This report provides an overview of the pipeline landscape for chronic respiratory diseases. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic devel ...

30-Nov-2018 $3995

Transplant Complications Drug Development Pipeline Review, 2018

By GBI Research

Summary This report provides an overview of the pipeline landscape for transplant complications. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic developme ...

30-Nov-2018 $3995

Epilepsy Therapeutics in Asia-Pacific Markets to 2024 - Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth

By GBI Research

Summary Epilepsy is a chronic disorder of the brain with substantial morbidity. There are more than 65 million people with epilepsy globally, and this is growing because of the rapidly increasing population. The rising pre ...

01-Nov-2018 $4995

Optic Nerve Disorders Drug Development Pipeline Review, 2018

By GBI Research

Optic Nerve Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve fibers that transmits visual information f ...

26-Oct-2018 $3995

Hereditary Hematological Disorders Drug Development Pipeline Review, 2018

By GBI Research

Hereditary Hematological Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for hereditary hematological disorders. It provides comprehensive information on th ...

25-Oct-2018 $3995

Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

By GBI Research

Orphan and rare dermatological diseases are considerably diverse in terms of pathophysiology, clinical presentation and disease severity. Many of these conditions are extremely debilitating and can even be life-threatening in some cases. D ...

11-Oct-2018 $6995

Dermatological Burns, Scars and Ulcers Drug Development Pipeline Review, 2018

By GBI Research

This report provides an overview of the pipeline landscape for dermatological burns, scars and ulcers. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pressure ulc ...

28-Sep-2018 $3995

Pain Drug Development Pipeline Review, 2018

By GBI Research

This report provides an overview of the pipeline landscape for pain disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for post-operative pain, fibromyalgia, c ...

24-Sep-2018 $3995

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018

By GBI Research

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for depression and anxiety disorders. It provides comprehensive information on th ...

21-Sep-2018 $3995

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth

By GBI Research

Global Orphan and Rare Dermatology Drugs Market to 2024 - An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth Summary Dermatology is a highly diverse ...

01-Sep-2018 $4995

Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy

By GBI Research

Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy Summary Heart failure (HF) is a life-threatening syndrome with ...

01-Sep-2018 $4995

Blood Pressure Disorders Drug Development Pipeline Review, 2018

By GBI Research

Blood Pressure Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for blood pressure disorders. It provides comprehensive information on the therapeutics under ...

31-Aug-2018 $3995

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

By GBI Research

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the ther ...

31-Aug-2018 $3995

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

By GBI Research

Summary Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of co ...

01-Aug-2018 $4995